← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

6,099

Price

$0

Filed

Mar 2

Insider

Name

Smith Hunter C

Title

Chief Financial Officer

CIK

0001636385

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

91,401

Footnotes

The options are fully vested.

Filing Info

Accession No.

0001104659-26-022440

Form Type

4

Issuer CIK

0001649904

Smith Hunter C's History

Date Ticker Type Value
2026-03-02 RYTM M $41K
2026-03-02 RYTM M $0
2026-02-19 RYTM $131K
2026-02-19 RYTM $171K
2026-02-19 RYTM $82K
2026-02-19 RYTM $60K
2026-02-17 RYTM $119K
2026-02-17 RYTM $20K
2026-02-17 RYTM $92K
2026-02-17 RYTM $110K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
$503K 2026-03-04
Mathers Edward T 2026-03-12
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$2.2M 2026-03-02
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11